- Home
- NTZ vs RLYB Comparison
NTZ vs RLYB Comparison
Compare NTZ & RLYB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NTZ
- RLYB
- Stock Information
- Founded
- NTZ 1959
- RLYB 2018
- Country
- NTZ Italy
- RLYB United States
- Employees
- NTZ N/A
- RLYB N/A
- Industry
- NTZ Home Furnishings
- RLYB Biotechnology: Pharmaceutical Preparations
- Sector
- NTZ Consumer Discretionary
- RLYB Health Care
- Exchange
- NTZ Nasdaq
- RLYB Nasdaq
- Market Cap
- NTZ 45.4M
- RLYB 45.2M
- IPO Year
- NTZ 1993
- RLYB 2021
- Fundamental
- Price
- NTZ $4.15
- RLYB $1.00
- Analyst Decision
- NTZ
- RLYB Buy
- Analyst Count
- NTZ 0
- RLYB 6
- Target Price
- NTZ N/A
- RLYB $8.10
- AVG Volume (30 Days)
- NTZ 3.4K
- RLYB 96.2K
- Earning Date
- NTZ 12-12-2024
- RLYB 11-07-2024
- Dividend Yield
- NTZ N/A
- RLYB N/A
- EPS Growth
- NTZ N/A
- RLYB N/A
- EPS
- NTZ N/A
- RLYB N/A
- Revenue
- NTZ $365,846,531.00
- RLYB $598,000.00
- Revenue This Year
- NTZ N/A
- RLYB N/A
- Revenue Next Year
- NTZ N/A
- RLYB N/A
- P/E Ratio
- NTZ N/A
- RLYB N/A
- Revenue Growth
- NTZ N/A
- RLYB N/A
- 52 Week Low
- NTZ $3.80
- RLYB $0.95
- 52 Week High
- NTZ $7.20
- RLYB $3.46
- Technical
- Relative Strength Index (RSI)
- NTZ 40.50
- RLYB 43.40
- Support Level
- NTZ $3.85
- RLYB $1.00
- Resistance Level
- NTZ $4.45
- RLYB $1.24
- Average True Range (ATR)
- NTZ 0.23
- RLYB 0.08
- MACD
- NTZ -0.08
- RLYB -0.01
- Stochastic Oscillator
- NTZ 18.18
- RLYB 7.59
About NTZ Natuzzi S.p.A.
Natuzzi SpA is an Italian firm that designs, manufactures, and sells contemporary and traditional leather and fabric-upholstered furniture. Its product portfolio including sofas, loveseats, armchairs, sectional furniture, motion furniture and sofa beds, living room furnishings, and accessories. The company markets its products under several brands such as Natuzzi Italia, Private label, and Natuzzi Editions. Geographically, it derives a majority of revenue from the United States of America and also has an international presence in Italy, Spain, UK and Other countries.
About RLYB Rallybio Corporation
Rallybio Corp is a clinical stage biotechnology company committed to identifying and accelerating the development of life-transforming therapies for patients with severe and rare disorders. Its program is for the prevention of fetal and neonatal alloimmune thrombocytopenia, a potentially life-threatening rare disease that can cause uncontrolled bleeding in fetuses and newborns.